162 related articles for article (PubMed ID: 7538482)
1. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
[TBL] [Abstract][Full Text] [Related]
2. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
3. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
4. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
5. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
[TBL] [Abstract][Full Text] [Related]
6. [Phenotypic analysis of immature T-lineage cells].
Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
Rinsho Byori; 1993 Sep; 41(9):966-75. PubMed ID: 8254974
[TBL] [Abstract][Full Text] [Related]
7. Human recombination activating gene-1 in leukemia/lymphoma cells: expression depends on stage of lymphoid differentiation defined by phenotype and genotype.
Yoneda N; Tatsumi E; Kawano S; Matsuo Y; Minowada J; Yamaguchi N
Blood; 1993 Jul; 82(1):207-16. PubMed ID: 8391873
[TBL] [Abstract][Full Text] [Related]
8. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.
Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K
Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526
[TBL] [Abstract][Full Text] [Related]
9. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.
Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM
Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525
[TBL] [Abstract][Full Text] [Related]
10. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
[TBL] [Abstract][Full Text] [Related]
11. Autocrine IL-2-dependent growth of a newly established CD3+, CD16-, CD56+, CD57+, J(H)-, TCRbeta-, TCRgamma- leukemia cell line (NOI-90).
Sahraoui Y; Perraki M; Theodoropoulou M; Allouche M; Tsapis A; Ammar A; Clemenceau C; Bokogiorgou S; Yacci T; Katrinakis G; Jasmin C; Georgoulias V
Leukemia; 1997 Feb; 11(2):245-52. PubMed ID: 9009088
[TBL] [Abstract][Full Text] [Related]
12. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
13. Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic Langerhans' cells.
Srivastava BI; Srivastava A; Srivastava MD
Leuk Res; 1994 Jul; 18(7):499-511. PubMed ID: 7912755
[TBL] [Abstract][Full Text] [Related]
14. CD56-positive acute lymphoblastic leukemia.
Matano S; Terahata S; Nakamura S; Kobayashi K; Sugimoto T
Acta Haematol; 2005; 114(3):160-3. PubMed ID: 16227680
[TBL] [Abstract][Full Text] [Related]
15. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity.
Koita H; Suzumiya J; Ohshima K; Takeshita M; Kimura N; Kikuchi M; Koono M
Am J Surg Pathol; 1997 Feb; 21(2):242-8. PubMed ID: 9042293
[TBL] [Abstract][Full Text] [Related]
16. CD3 delta and epsilon gene expression in CD3-CD16+ natural killer cell clones derived from thymic precursors.
DeNofrio D; Radcliff G; Weinhold KJ; Denning SM
Hum Immunol; 1995 Aug; 43(4):283-94. PubMed ID: 7499176
[TBL] [Abstract][Full Text] [Related]
17. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
[TBL] [Abstract][Full Text] [Related]
18. Acute leukemia with the phenotype of a natural killer/T cell bipotential precursor.
Ino T; Tsuzuki M; Okamoto M; Shamoto M; Hirano M
Ann Hematol; 1999 Jan; 78(1):43-7. PubMed ID: 10037270
[TBL] [Abstract][Full Text] [Related]
19. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
20. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
